Еверолимус Майлан

Everolimus Mylan is an oral immunosuppressant used to prevent organ transplant rejection and treat certain cancers. This EU-sourced medication is available for prescription-based purchase. Always consult a healthcare professional before use.

Everolimus is primarily used to prevent organ transplant rejection in kidney and heart transplant patients. It is also prescribed to treat advanced kidney cancer, certain types of pancreatic and breast cancers, and tuberous sclerosis complex-related conditions. Patients often ask, 'what is everolimus used for' to understand its broad therapeutic applications beyond transplant care.

Everolimus works by inhibiting specific proteins that regulate cell growth and immune responses, helping to maintain organ function post-transplant. Users may notice improved stability in their condition over time, though individual responses vary. Common effects include reduced risk of rejection episodes and slowed progression in cancer management.

Store everolimus at room temperature, away from moisture and direct light. Keep the medication in its original packaging until ready to use. Always handle with care, ensuring it is out of reach of children and pets. Report any unusual symptoms to a healthcare provider promptly.

Everolimus may interact with other immunosuppressants, CYP3A4 inhibitors or inducers, and certain antibiotics or antifungals. Alcohol and grapefruit products can also affect its metabolism. Always inform your doctor about all medications and supplements you are taking to avoid potential interactions.